{
    "Trade/Device Name(s)": [
        "Multigent Lithium"
    ],
    "Submitter Information": "Sentinel CH. SpA",
    "510(k) Number": "K070987",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003583"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NDW"
    ],
    "Summary Letter Date": "June 21, 2007",
    "Summary Letter Received Date": "June 25, 2007",
    "Submission Date": "March 30, 2007",
    "Regulation Number(s)": [
        "21CFR862.3560"
    ],
    "Regulation Name(s)": [
        "Lithium Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Lithium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c8000 System",
        "AEROSET System",
        "Hitachi 911 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Multigent Lithium spectrophotometric assay for measuring lithium in serum or plasma on ARCHITECT c8000 and AEROSET analyzers.",
    "Indications for Use Summary": "Intended for measurement of lithium in serum or plasma to aid in managing individuals on lithium therapy for mental disturbances such as bipolar disorder, for use on Architect and Aeroset analyzers.",
    "fda_folder": "Toxicology"
}